Background. Sialyl Lewis-x (sLx) is a cellular adhesion molecule (CAM)
that has been implicated in the inflammatory reaction and cancer meta
stasis. The sLx is the carbohydrate ligand of endothelial-selectin (E-
selectin), an inducible vascular endothelial CAM. The role of sLx has
been investigated in several cancers, and its presence has been correl
ated with advanced disease stage, decreased disease-free survival, and
greater metastatic potential. A recent study has found that cultured
head and neck (HN) squamous cell carcinoma (SCC) cell lines express sL
x and that binding of these cells to cytokine activated endothelium co
rrelates with the endothelial expression of E-selectin. The purpose of
this study was to identify six in the tumors of patients with HNSCC a
nd to see ii the presence of sLx correlated with disease status. Metho
ds. We performed immunohistochemical (IHC) staining to detect the sLx
antigen using the monoclonal antibody (MAb) KM-93. Eighty-two specimen
s of HNSCC that were obtained at the time of resection or biopsy were
analyzed for sLx staining patterns and intensities. The clinical outco
mes of survival, disease-free interval, and incidence of distant metas
tasis were then assessed to determine whether there was a correlation
with sLx tumor expression. In addition;we analyzed specimens from meta
static HNSCC sites for expression of sLx. Results. The sLx expression
was identified in 62% of the primary tumor specimens and 87% of the me
tastatic tumor specimens analyzed by IHC. The staining pattern in the
HNSCC tumors differed from that seen in normal squamous epithelium but
was variable in both intensity and distribution. The sLx expression i
n the metastatic sites was higher than in the primary sites in 67% of
the specimens (10 of 15). There was no correlation between sLx stainin
g and disease status. Conclusions. The results of this study demonstra
te that sLx is present in HNSCC and supports the data that show that s
Lx may play a role in the metastasis of HNSCC. Future studies are warr
anted to evaluate the role of six, E-selectin, and other CAMs in HNSCC
. (C) 1998 John Wiley & Sons, Inc.